Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.

Dow Jones2021-11-17

MW Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.

 

$(END)$ Dow Jones Newswires

November 17, 2021 06:05 ET (11:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法